Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Ask A Vaccine Specialist: What Does The Future of the mRNA Platform Hold?


Recently authorized coronavirus vaccines from Moderna (NASDAQ: MRNA) and the Pfizer (NYSE: PFE)-BioNTech (NASDAQ: BNTX) team are the first messenger RNA (mRNA) vaccines ever to be commercialized. Dr. Bruce Gellin of the Sabin Vaccine Institute joined Corinne Cardina and Olivia Zitkus of Fool.com's Healthcare and Cannabis Bureau on a Dec. 18 episode of Fool Live to talk about some of the possibilities of the mRNA platform in vaccine and drug development. 

Continue reading


Source Fool.com

Like: 0
Share

Comments